NCT04194775 2025-12-11A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular CarcinomaCStone PharmaceuticalsPhase 3 Active not recruiting534 enrolled
NCT03523819 2024-09-19A Study of CS1002 in Subjects with Advanced Solid TumorsCStone PharmaceuticalsPhase 1 Completed91 enrolled
NCT03475251 2022-02-18A Study of CS1003 in Subjects With Advanced Solid TumorsCStone PharmaceuticalsPhase 1 Completed108 enrolled